NCT00600496 2025-11-13A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)AstraZenecaPhase 1 Active not recruiting140 enrolled
NCT02664935 2025-05-21National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung CancerUniversity of BirminghamPhase 2 Active not recruiting423 enrolled